Guided by a vision for the future, Africa, endowed with enormous medicinal flora and fauna, should not be considered a marginal player in global pharmacy practice. This is even more evident given that African ethnobotany has consistently proven to be among the most efficacious in drug discovery and disease treatment. Hence, there is an urgent need to rethink pharmacy practice through an Afrofuturist lens.
Grappling with the reality that African countries import between 70 and 90 per cent of their medicines represents a structural deficiency demanding urgent and innovative solutions. The truth remains: Africa consumes what it could invent, dispenses what it could discover, and regulates what it did not formulate.
Afrofuturism, often popularised in cultural discourse through works like Black Panther, does not end with aesthetics or speculative fiction. It is a philosophical repositioning that resists epistemic violence, particularly the marginalisation of African knowledge systems. It probes the future of the world when African people, knowledge, and institutions become central rather than peripheral to global civilisation.
Applied to pharmacy practice, it calls for a transition from survivalist models to pace-setting, innovative approaches. It inspires the development of pharmaceutical systems rooted in African agency, scientific originality, and technological ambition.
Pharmacy practice in Africa has largely operated within colonial structures. Curricula mirror imported templates. Regulatory frameworks are fashioned after global benchmarks. Drug supply chains depend heavily on external manufacturing ecosystems. The COVID-19 pandemic exposed the continent’s fragility when vaccine inequity left many African countries stranded at the crossroads of urgent need. While harmonisation is invaluable in a globalised world, dependency stifles innovation.
Afrofuturism, therefore, challenges African pharmacists to imagine a novel architecture of practice, where African laboratories no longer play secondary roles but endure as primary sites of innovation. Already, several African biotech startups and research centres, including those in Nigeria, South Africa, and Kenya, are demonstrating that vaccine development, clinical trials, and novel drug discovery can thrive locally when supported by infrastructure and investment. Scaling such initiatives across the continent is central to the Afrofuturist vision.
In terms of ethnobotany, Africa is home to tens of thousands of medicinal plants with documented therapeutic and prophylactic properties. The United Nations Environment Programme confirms that indigenous communities across the continent have long developed sophisticated knowledge based on plant chemistry, dosage patterns, and ecological rhythms. Yet this knowledge is often dismissed as informal and relegated to the margins of modern healthcare, even though modern pharmacology itself is rooted in plant isolation and molecular refinement.
An Afrofuturist lens does not merely romanticise African ethnobotany, nor does it ignore its inherent value. Instead, it seeks to integrate this insight with rigorous pharmacognosy, clinical trials, and quality assurance. It asks: why should the next global revolution in phytopharmaceutical innovation not emanate from an African research institute, patented and produced on African soil? By fostering collaborations between traditional healers, chemists, and pharmacists, African pharmaceutical systems could pioneer therapies for diseases that disproportionately affect the continent, while also contributing to global health solutions.
This question transcends sentimentality, given the statistics that highlight Sub-Saharan Africa’s disproportionate share of the global burden of infectious diseases, including the majority of malaria deaths, according to the World Health Organisation. Meanwhile, the rapid rise of non-communicable diseases strains already insufficient health infrastructure. Pharmaceutical sovereignty, therefore, is imperative. How can Africa respond when public health systems buckle under institutional decay? Afrofuturism in pharmacy imagines resilient manufacturing hubs, AI-driven distribution networks tailored to rural geographies, and regulatory bodies that are both globally compliant and locally assertive.
For decades, the narrative surrounding African healthcare has been grim. The continent has often been portrayed as a site of intervention rather than a hub of invention. Afrofuturism seeks to obliterate this perception and reimagine Africa as a centre of healthcare innovation and efficiency. Global media frequently highlights epidemic-ravaged African towns in need of international aid, even amid endemic corruption affecting political elites. Decisions such as U.S. President Donald Trump’s withdrawal of certain medical funding through agencies like USAID underscore Africa’s vulnerability.
Yet, viewed through an Afrofuturist lens, such moments serve as wake-up calls for African leaders to prioritise domestic investment in health. Strengthening local research, manufacturing, and regulatory capacity is no longer optional; it is a necessity if Africa is to claim its rightful place in shaping the future of global pharmacy.
